Rocket Lab (NASDAQ: RKLB) has demonstrated remarkable growth, reporting a 63.5% year-over-year revenue surge in Q1 2024, reaching $200.35 million. The company’s $2.20 billion backlog and its recent announcement of an $8 billion acquisition of Iridium Communications signal ambitious expansion.
Wall Street remains bullish, with a consensus target price of $114.10 (3 strong buys, 11 buys, 4 holds, 0 sells). Our base-case projection stands at $124.25, offering 33.48% upside, while an optimistic scenario reaches $156.80. However, the path to $175 hinges on three catalysts: successful Neutron rocket launches in Q4 2026, timely completion of the Iridium acquisition by mid-2027, and sustained backlog conversion at Q1’s 63.5% growth rate. CEO Peter Beck emphasized on the Q1 call, “We’re embedded in the most demanding and significant space programs of our generation,” though delays in Neutron’s timeline could derail these expectations.
To justify a $175 valuation, Rocket Lab must leverage its 92x sales multiple against 63.5% quarterly revenue growth and capitalize on contracts like the $816 million SDA Tranche 3 and NASA’s PolSIR/TSIS-2 missions. Investors are essentially betting on Rocket Lab evolving from a small-launch provider into a comprehensive space infrastructure player by 2028. While ambitious, this outlook aligns with the company’s five-year 704.58% return and 161.05% annual gains, suggesting a strategy as high-risk, high-reward as Rocket Lab’s peers.